In an earlier study [80], which was designed to identify the roles of COX-2 and HER2 in VEGF-C expression and lymphangiogenesis, we used 65 human breast cancer tissue samples and multiple human breast cancer cell line that was genetically manipulated for COX-2 and HER2 expression. This evidence concerns the gene VEGFC and breast carcinoma.